We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Pfizer's 2021 profits doubled to US$22 bn on strong Covid vaccine sales | New Straits Times
Business Business Headlines News
NSTworld Pfizer forecast more than US$50 billion in 2022 sales for its Covid19 vaccine and therapeutic as the giant pharma company reported a more than doubling of annual profits on strong vaccine sales.